Leukemia, Lymphocytic, Chronic, B-CellLeukemia, LymphoidPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemiaSurvival RateLeukemia, Myeloid, AcuteLeukemia, B-CellCell SurvivalAsparaginaseLeukemic InfiltrationSurvival AnalysisLeukemia, T-CellPrognosisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveVidarabinePrecursor B-Cell Lymphoblastic Leukemia-LymphomaMethotrexateB-LymphocytesLeukemia, Biphenotypic, AcuteVincristineBone MarrowTreatment OutcomeAntineoplastic AgentsAntineoplastic Combined Chemotherapy ProtocolsRemission, SpontaneousRemission InductionCytarabineLymphocytes, NullGene Expression Regulation, LeukemicDisease-Free Survival6-MercaptopurineLeukemia, ExperimentalImmunoglobulin Heavy ChainsLeukemia-Lymphoma, Adult T-CellLymphomaTime FactorsReceptors, Antigen, B-CellBurkitt LymphomaZAP-70 Protein-Tyrosine KinaseChlorambucilRetrospective StudiesLeukemia, Hairy CellRosette FormationRecurrenceDNA, NeoplasmCyclophosphamideKaryotypingChromosomes, Human, 6-12 and XPhiladelphia ChromosomeAnisocoriaLymphocytesTumor Cells, CulturedAntibodies, MonoclonalCorneal PerforationAcute DiseaseAntigens, NeoplasmChromosome AberrationsT-LymphocytesBlast CrisisLeukemia Virus, MurineCladribineTranslocation, GeneticDrug Resistance, NeoplasmPrednisoneLeukemia, MyeloidAntigens, CD5MutationFusion Proteins, bcr-ablApoptosisDNA NucleotidylexotransferaseNeoplasm ProteinsAntigens, CD38Graft SurvivalSurvivalBone Marrow TransplantationKaplan-Meier EstimateNeoplasm StagingDrug Administration ScheduleFollow-Up StudiesImmunoglobulin Variable RegionFlow CytometryBase SequenceDaunorubicinChromosomes, Human, Pair 14NeprilysinSalvage TherapyDoxorubicinCell Line, TumorMolecular Sequence DataAntigens, SurfaceAntibodies, Monoclonal, Murine-DerivedTransplantation, HomologousRisk FactorsPolymerase Chain ReactionDexamethasoneCombined Modality TherapyLeukemia, Prolymphocytic, T-CellProto-Oncogene ProteinsImmunophenotypingCyclin-Dependent Kinase Inhibitor p15